Episurf Medical AB (publ) (EPIS-B.ST) has a MoatMap StockRank of 26/100 based on Quality (24/100), Value (36/100), and Momentum (53/100) factor scores. The current signal is SELL. Episurf Medical is a small-cap medical device company. It is unprofitable and lacks the scale, distribution network, or pricing power required to compete with global orthopedic giants.
Episurf Medical AB is a medical technology company that designs and manufactures patient-specific implants and surgical instruments for treating joint damage. Utilizing its proprietary 3D imaging and design platform, the company produces the Episealer implant, tailored precisely to each patient's unique anatomy to preserve healthy joint tissue. Episurf's competitive advantage is rooted in its personalized medicine approach, which bridges the gap between early-stage conservative treatments and total joint replacement.
| Price | $0.01 |
| Market Cap | $83M |
| P/E (Forward) | -0.97 |
| Price/Book | 3.33 |
| Return on Equity | -88.7% |
| Return on Invested Capital | -116.2% |
| Debt/Equity | 10.32 |
| Gross Margin | 50.0% |
| Operating Margin | -289.6% |
| Revenue Growth | -20.0% |
| Free Cash Flow | $-476K |
Episurf Medical AB (publ) operates in the Medical Devices industry, part of the Healthcare sector (Sweden).